Clear Harbor Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,552
Closed -$232K 481
2025
Q4
$232K Buy
4,552
+462
+11% +$23.6K 0.02% 397
2025
Q3
$227K Sell
4,090
-5,606
-58% -$328K 0.02% 381
2025
Q2
$669K Sell
9,696
-1,705
-15% -$116K 0.05% 241
2025
Q1
$792K Buy
11,401
+7,079
+164% +$585K 0.06% 203
2024
Q4
$372K Buy
4,322
+694
+19% +$75K 0.03% 286
2024
Q3
$432K Buy
3,628
+172
+5% +$22.9K 0.04% 254
2024
Q2
$493K Hold
3,456
0.04% 222
2024
Q1
$444K Sell
3,456
-59
-2% -$7.02K 0.04% 236
2023
Q4
$364K Sell
3,515
-301
-8% -$29.8K 0.03% 259
2023
Q3
$347K Hold
3,816
0.04% 252
2023
Q2
$309K Buy
+3,816
New +$312K 0.03% 268
2020
Q4
Sell
-800
Closed -$27.8K 595
2020
Q3
$27.8K Buy
+800
New +$26.7K ﹤0.01% 461
2020
Q1
Sell
-800
Closed -$23.2K 556
2019
Q4
$23.2K Buy
+800
New +$22.2K ﹤0.01% 501

Other funds holding NVO

Clear Harbor Asset Management's NVO Position: Q1 2026 in Review

Clear Harbor Asset Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,552 shares — an estimated $232K sold.

Clear Harbor Asset Management first reported a position in NVO in Q4 2019 and held it in 13 quarters. The position peaked at $792K in Q1 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Clear Harbor Asset Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Clear Harbor Asset Management sold 4,552 Novo Nordisk shares in Q1 2026, an estimated $232K.
  • Clear Harbor Asset Management first reported a position in Novo Nordisk in Q4 2019 and held it in 13 quarters.
  • Clear Harbor Asset Management's Novo Nordisk position peaked at $792K in Q1 2025.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Clear Harbor Asset Management's 13F filing for Q1 2026, filed 5 May 2026.